Statements (28)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:monoclonal_antibody
|
| gptkbp:administeredBy |
gptkb:chlorambucil
|
| gptkbp:alsoKnownAs |
gptkb:obinutuzumab
|
| gptkbp:approvedBy |
gptkb:FDA
2013 chronic lymphocytic leukemia follicular lymphoma |
| gptkbp:ATCCode |
L01XC10
|
| gptkbp:CASNumber |
942967-86-2
|
| gptkbp:developedBy |
gptkb:Genentech
gptkb:Roche |
| https://www.w3.org/2000/01/rdf-schema#label |
Gazyva
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:marketedIn |
gptkb:European_Union
gptkb:Japan gptkb:United_States |
| gptkbp:mechanismOfAction |
anti-CD20 antibody
|
| gptkbp:pregnancyCategory |
not recommended
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
infections
neutropenia thrombocytopenia infusion reactions |
| gptkbp:target |
gptkb:CD20
|
| gptkbp:type |
humanized monoclonal antibody
|
| gptkbp:UNII |
6X9OC3H4II
|
| gptkbp:bfsParent |
gptkb:Roche
|
| gptkbp:bfsLayer |
6
|